Descartes-08 for Patients With Systemic Lupus Erythematosus

NCT06038474 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)

Interventions

DRUG: Descartes-08

Sponsor

Cartesian Therapeutics